{"id":"https://openalex.org/W4385334752","doi":"https://doi.org/10.3389/fmed.2023.1225710","title":"Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial","display_name":"Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: a post-hoc analysis of the phase 3 OPTIC trial","publication_year":2023,"publication_date":"2023-07-28","ids":{"openalex":"https://openalex.org/W4385334752","doi":"https://doi.org/10.3389/fmed.2023.1225710","pmid":"https://pubmed.ncbi.nlm.nih.gov/37575994","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10420047"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2023.1225710","doi":"https://doi.org/10.3389/fmed.2023.1225710","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1225710","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmed.2023.1225710/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fmed.2023.1225710/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050734777","display_name":"George David Rodriguez","orcid":"https://orcid.org/0000-0003-2209-205X","observed_orcids":["https://orcid.org/0000-0003-2209-205X"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"George D. Rodriguez","raw_affiliation_strings":["Columbia University School of Nursing, New York, NY, United States","Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University School of Nursing, New York, NY, United States","institution_ids":["https://openalex.org/I78577930"]},{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047389598","display_name":"Nathan Warren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan Warren","raw_affiliation_strings":["Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042748385","display_name":"Roman Yashayev","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman Yashayev","raw_affiliation_strings":["Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antimicrobial Stewardship, New York-Presbyterian Queens, Flushing, NY, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062874736","display_name":"Surya Chitra","orcid":"https://orcid.org/0000-0002-5682-9200","observed_orcids":["https://orcid.org/0000-0002-5682-9200"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surya Chitra","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053081800","display_name":"Maria I Amodio-Groton","orcid":"https://orcid.org/0000-0002-4846-9284","observed_orcids":["https://orcid.org/0000-0002-4846-9284"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria Amodio-Groton","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States","institution_ids":["https://openalex.org/I4210101063"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072370749","display_name":"Kelly Wright","orcid":"https://orcid.org/0000-0003-2908-2612","observed_orcids":["https://orcid.org/0000-0003-2908-2612"]},"institutions":[{"id":"https://openalex.org/I4210101063","display_name":"Paratek Pharmaceuticals (United States)","ror":"https://ror.org/019g7bh20","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101063"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kelly Wright","raw_affiliation_strings":["Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paratek Pharmaceuticals, Inc., King of Prussia, PA, United States","institution_ids":["https://openalex.org/I4210101063"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072370749"],"corresponding_institution_ids":["https://openalex.org/I4210101063"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":1.4478,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.79449799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":98},"biblio":{"volume":"10","issue":null,"first_page":"1225710","last_page":"1225710"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omadacycline","display_name":"omadacycline","score":0.9639999866485596},{"id":"https://openalex.org/keywords/community-acquired-bacterial-pneumonia","display_name":"community-acquired bacterial pneumonia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/moxifloxacin","display_name":"moxifloxacin","score":0.8550000190734863},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.8560000061988831},{"id":"https://openalex.org/keywords/pneumonia-severity-index","display_name":"Pneumonia Severity Index","score":0.8840000033378601},{"id":"https://openalex.org/keywords/aminomethylcycline","display_name":"aminomethylcycline","score":0.781000018119812},{"id":"https://openalex.org/keywords/antibiotic-safety","display_name":"antibiotic safety","score":0.5049999952316284},{"id":"https://openalex.org/keywords/early-clinical-response","display_name":"early clinical response","score":0.6470000147819519},{"id":"https://openalex.org/keywords/atypical-pathogens","display_name":"atypical pathogens","score":0.4970000088214874},{"id":"https://openalex.org/keywords/streptococcus-pneumoniae","display_name":"Streptococcus pneumoniae","score":0.8629999756813049},{"id":"https://openalex.org/keywords/haemophilus-influenzae","display_name":"Haemophilus influenzae","score":0.8289999961853027},{"id":"https://openalex.org/keywords/mycoplasma-pneumoniae","display_name":"Mycoplasma pneumoniae","score":0.6759999990463257}],"concepts":[{"id":"https://openalex.org/C2778836808","wikidata":"https://www.wikidata.org/wiki/Q424940","display_name":"Moxifloxacin","level":3,"score":0.9444714784622192},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8482218980789185},{"id":"https://openalex.org/C2776345407","wikidata":"https://www.wikidata.org/wiki/Q3776920","display_name":"Bacterial pneumonia","level":3,"score":0.6231903433799744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.620047926902771},{"id":"https://openalex.org/C2776102371","wikidata":"https://www.wikidata.org/wiki/Q460030","display_name":"Community-acquired pneumonia","level":3,"score":0.52232426404953},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5214152336120605},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.5150487422943115},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5129472613334656},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4964662194252014},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.49117252230644226},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.48589056730270386},{"id":"https://openalex.org/C67761136","wikidata":"https://www.wikidata.org/wiki/Q2105849","display_name":"Post-hoc analysis","level":2,"score":0.4327560067176819},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3823603391647339},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fmed.2023.1225710","doi":"https://doi.org/10.3389/fmed.2023.1225710","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1225710","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmed.2023.1225710/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10420047","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10420047","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10420047/pdf/fmed-10-1225710.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Med (Lausanne)","raw_type":"Text"},{"id":"pmid:37575994","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37575994","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:88291b39d6d44b30a5e320c83d906fa1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/88291b39d6d44b30a5e320c83d906fa1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Medicine, Vol 10 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2023.1225710","doi":"https://doi.org/10.3389/fmed.2023.1225710","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2023.1225710","pdf_url":"https://www.frontiersin.org/articles/10.3389/fmed.2023.1225710/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385334752.pdf","grobid_xml":"https://content.openalex.org/works/W4385334752.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1492094249","https://openalex.org/W2002222742","https://openalex.org/W2007997355","https://openalex.org/W2088961121","https://openalex.org/W2101812185","https://openalex.org/W2124529821","https://openalex.org/W2152406312","https://openalex.org/W2168841364","https://openalex.org/W2252619100","https://openalex.org/W2523533059","https://openalex.org/W2561278236","https://openalex.org/W2914722304","https://openalex.org/W2953838561","https://openalex.org/W2957226098","https://openalex.org/W2958814422","https://openalex.org/W2965134454","https://openalex.org/W2977322360","https://openalex.org/W3023315688","https://openalex.org/W3185434801","https://openalex.org/W3214085457","https://openalex.org/W3215879321","https://openalex.org/W4231866474","https://openalex.org/W4242318543","https://openalex.org/W4309852219","https://openalex.org/W4318591457","https://openalex.org/W7214245626"],"related_works":["https://openalex.org/W4416440525","https://openalex.org/W4410276897","https://openalex.org/W2745806880","https://openalex.org/W7122627266","https://openalex.org/W3126040136","https://openalex.org/W3174893781","https://openalex.org/W2914722304","https://openalex.org/W7151366732","https://openalex.org/W7202213377","https://openalex.org/W2047049170"],"abstract_inverted_index":{"Introduction":[0],"The":[1,171],"2019":[2],"American":[3],"Thoracic":[4],"Society/Infectious":[5],"Disease":[6],"Society":[7],"of":[8,39,59,81,104,126,134,153,191,238,249,268,346],"America":[9],"guidelines":[10],"recommend":[11],"respiratory":[12],"fluoroquinolones":[13,60,269],"to":[14,92,259],"treat":[15],"community-acquired":[16],"bacterial":[17],"pneumonia":[18],"(CABP)":[19],"in":[20,221,227,279,315],"adults":[21],"with":[22,100,129,138,184,200,204,211,253,277,302,317,338],"comorbidities.":[23,323],"Fluoroquinolones":[24],"are":[25,70],"effective":[26],"against":[27,282],"both":[28,308],"typical":[29],"and":[30,42,45,74,106,123,146,165,186,206,225,242,266,291,310,322],"atypical":[31,292],"pathogens.":[32],"However,":[33],"fluoroquinolone":[34,82,250],"treatment":[35,88,133,333],"has":[36,48,61],"a":[37,64,86,101,110,150,271,296],"risk":[38,143,319],"adverse":[40],"effects,":[41],"the":[43,79,121,132,154,222,228,247,263,283,344],"Food":[44],"Drug":[46],"Administration":[47],"issued":[49],"black":[50],"box":[51],"safety":[52,122,299],"warnings":[53,233],"for":[54,78,131,198,208,216,246,335],"their":[55],"use.":[56,83,251],"Inpatient":[57],"use":[58,237,345],"reduced":[62,235],"as":[63,72,109,270,329],"result;":[65],"however,":[66,240],"most":[67,284],"antibiotic":[68,99],"courses":[69],"completed":[71],"outpatients":[73],"discharge":[75,243],"prescriptions":[76,244],"account":[77,245],"majority":[80,248],"As":[84],"such,":[85],"new":[87],"option":[89,276,334],"is":[90,96,107],"needed":[91],"replace":[93],"fluoroquinolones.":[94,260,347],"Omadacycline":[95,261,324],"an":[97,256,326,330],"aminomethylcycline":[98],"broad":[102],"spectrum":[103],"activity":[105,281],"available":[108],"once-daily":[111],"intravenous":[112],"or":[113],"bioequivalent":[114,274],"oral":[115,275,331],"formulation.":[116],"Methods":[117],"This":[118],"study":[119,158],"assessed":[120],"clinical":[124,194],"efficacy":[125,265,314],"omadacycline":[127,205,223,309],"compared":[128],"moxifloxacin":[130,229,311],"adult":[135,336],"CABP":[136,286],"patients":[137,168,199,316,337],"Pneumonia":[139],"Severity":[140],"Index":[141],"(PSI)":[142],"class":[144,320],"II/III":[145,321],"\u22651":[147,201],"comorbidity":[148,202],"through":[149],"post-hoc":[151],"analysis":[152],"phase":[155],"3":[156],"OPTIC":[157],"(NCT02531438).":[159],"Results":[160],"In":[161,306],"total,":[162],"239":[163],"omadacycline-":[164],"222":[166],"moxifloxacin-treated":[167],"were":[169,219],"assessed.":[170],"median":[172],"age":[173],"was":[174,196],"similar":[175,264,313],"between":[176],"groups":[177],"(omadacycline:":[178],"57":[179],"years;":[180],"moxifloxacin:":[181],"58":[182],"years),":[183],"26.0%":[185],"26.6%,":[187],"respectively,":[188],"\u226565":[189],"years":[190],"age.":[192],"Early":[193],"response":[195,218],"91.6%":[197],"treated":[203,210],"91.4%":[207],"those":[209],"moxifloxacin.":[212],"Post-treatment":[213],"evaluation":[214],"results":[215],"overall":[217],"89.1%":[220],"group":[224],"87.4%":[226],"group.":[230],"Conclusion":[231],"Safety":[232],"have":[234],"inpatient":[236],"fluoroquinolones;":[239],"outpatient":[241],"Outpatients":[252],"comorbidities":[254],"need":[255,328],"efficacious":[257],"alternative":[258],"maintains":[262],"benefits":[267],"once-daily,":[272],"monotherapy,":[273],"potent":[278],"vitro":[280],"common":[285],"pathogens,":[287,293],"including":[288],"S.":[289],"pneumoniae":[290],"but":[294],"offers":[295],"materially":[297],"different":[298],"profile":[300],"consistent":[301],"its":[303],"tetracycline":[304],"heritage.":[305],"conclusion,":[307],"exhibited":[312],"PSI":[318],"fulfills":[325],"unmet":[327],"monotherapy":[332],"CABP,":[339],"which":[340],"will":[341],"further":[342],"reduce":[343],"Clinical":[348],"trial":[349],"registration":[350],"https://www.clinicaltrials.gov/study/NCT02531438":[351],",":[352,356],"identifer:":[353],"NCT02531438;":[354],"https://www.clinicaltrialsregister.eu/ctr-search/search?query=2013-004071-13":[355],"identifier:":[357],"EudraCT":[358],"#2013-004071-13.":[359]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-07-29T00:00:00"}